Raymond James targets Addus HomeCare stock at USD 137.00
Raymond James has set a price target of USD 137.00 for Addus HomeCare, initiating coverage with an Outperform rating. This target reflects optimism about the company's growth potential through home-based care demand and acquisitions, following an 8% increase in second-quarter revenue. However, BofA Securities offered a contrasting view, cutting its target and downgrading the stock due to concerns about slower organic growth.
Why home health expansions are a power play in value-based care
The article discusses how home health expansions by companies like Bayada and Addus HomeCare are strategic moves to secure value-based care contracts. These expansions are highlighted as a significant power play within the evolving landscape of healthcare.
Addus HomeCare stock gets a USD 137.00 target from Raymond James
Raymond James has initiated coverage on Addus HomeCare (ADUS) with an Outperform rating and a $137.00 price target. This comes as Addus prepares to integrate its acquisition of AccentCare's personal care business, which is expected to add $280.0 million in annualized personal-care revenue. The company recently reported Q2 revenue of $377.40 million, an 8.00 percent increase year-over-year, and will announce its next earnings on November 2, 2026.
Addus HomeCare stock initiated at Outperform by Raymond James
Raymond James initiated coverage on Addus HomeCare (NASDAQ:ADUS) with an Outperform rating and a $137 price target, citing sustained growth potential through organic expansion and acquisitions in the home-based care sector. The firm believes the stock is undervalued at current levels, with a P/E ratio of 19.75 and a PEG ratio of 0.75. Addus HomeCare recently acquired AccentCare for approximately $275 million, which is expected to add nearly 20% to revenue and improve margins.
Addus HomeCare stock initiated at Outperform by Raymond James
Raymond James initiated coverage on Addus HomeCare (NASDAQ: ADUS) with an Outperform rating and a $137.00 price target, noting the stock appears undervalued according to InvestingPro's Fair Value analysis. The firm anticipates sustained growth through organic expansion and acquisitions, such as the recent AccentCare purchase. This positive outlook comes despite recent news of a BofA Securities downgrade and investor focus on the limited extent of the company's recent earnings beat.
Addus HomeCare Corporation (ADUS) Stock Price, News, Quote & History
Addus HomeCare Corporation (ADUS) closed at $114.05 with a slight decrease of 0.77% during regular trading hours, and remained unchanged in after-hours trading. The company, which provides personal care, hospice, and home health services, has seen a YTD return of 6.20% and a 5-year return of 37.38%. An analyst from B of A Securities recently downgraded the stock to Neutral and lowered its price target from $140 to $125.
Addus HomeCare To Acquire AccentCare Personal Care Business For $275 Million, Adding $280 Million In Annualized Revenue
Addus HomeCare is set to acquire AccentCare's personal care operations, excluding New York, for approximately $275 million. This acquisition is projected to add $280 million in annualized revenue, expanding Addus's national home care platform and increasing its revenue base by roughly 19%. The deal significantly strengthens Addus's presence in several key states and is expected to be accretive to its financial results.
Addus HomeCare to Acquire AccentCare Personal Care Business for $275 Million
Addus HomeCare Corporation has announced an agreement to acquire the majority of AccentCare’s personal care operations for approximately $275 million. This strategic acquisition will expand Addus HomeCare's platform across 10 states, add an estimated $280 million in annualized revenue, and significantly increase its customer base and geographic density in key markets. The deal is expected to be accretive to Addus’s financial results and aligns with its strategy of building a scaled, multi-state home care platform.
A $275 million home-care deal would serve about 13,700 customers a day. Addus needs regulatory approvals.
Addus HomeCare (ADUS) has announced a definitive agreement to acquire the personal care division of AccentCare for approximately $275 million. This acquisition is expected to add about $280 million in annualized revenue, representing a 19% increase for Addus, and will significantly expand its personal care operations across ten states, particularly in Texas, Illinois, California, and Arizona. The transaction, which is subject to regulatory approvals, aims to deepen Addus' operational presence and enhance its collaboration with managed care organizations and value-based care partners.
Addus, AccentCare Align Around Core Businesses In $275M Home Care Deal
Addus HomeCare Corporation plans to acquire AccentCare's personal care division for $275 million, with the deal expected to close in Q1 2027. This acquisition will expand Addus's presence into six new states, serving approximately 13,700 clients and deepening its penetration in the personal care market. For AccentCare, the divestiture allows them to refocus on their core Medicare home health, hospice, and palliative services.
Addus HomeCare to Acquire AccentCare's Personal and Community Care Business Outside New York for $275M
Addus HomeCare has entered into an agreement to acquire AccentCare’s personal and community care business, excluding its New York operations, for $275 million in cash. The acquisition is contingent upon regulatory approvals and the expiration of the Hart-Scott-Rodino Waiting Period, with Addus HomeCare having secured insurance and facing no financing conditions. This strategic move aims to expand Addus HomeCare's presence in the personal and community care sector.
Addus HomeCare to acquire AccentCare personal care unit for $275m
Addus HomeCare Corporation announced it will acquire the personal care division of AccentCare for approximately $275 million. This acquisition, which excludes AccentCare's hospice and home health operations, is expected to add around $280 million in annualized revenue to Addus, increasing its revenue base by roughly 19%. The deal significantly expands Addus's personal care services across ten states.
Addus Advances M&A Strategy With Deal for AccentCare Personal Care Business
Addus HomeCare (ADUS) has agreed to acquire AccentCare's personal care operations, excluding those in New York. This acquisition signifies a strategic advancement in Addus's merger and acquisition strategy. The full details of this deal are available to premium subscribers.
Addus HomeCare Announces a Definitive Agreement to Acquire Personal Care Division of AccentCare
Addus HomeCare Corporation has announced a definitive agreement to acquire the personal care division of AccentCare for approximately $275.0 million. This acquisition is expected to add around $280 million in annualized revenue, expanding Addus' personal care operations across ten states, including significant growth in Texas, Illinois, California, and Arizona. The transaction aligns with Addus' strategic growth initiatives, aiming to deepen its operational presence and enhance collaboration with managed care organizations.
Addus HomeCare to acquire AccentCare personal care unit for $275m
Addus HomeCare Corporation has announced a definitive agreement to acquire the personal care division of AccentCare for approximately $275 million. This acquisition, which excludes AccentCare's hospice and home health operations, is expected to add about $280 million in annualized revenue to Addus, increasing its revenue base by roughly 19%. The deal will significantly expand Addus’ personal care services across multiple states and is anticipated to be accretive to its financial results.
Addus HomeCare to Participate in the 2026 Jefferies Healthcare Services and Technology Conference
Addus HomeCare Corporation announced its participation in the 2026 Jefferies Healthcare Services and Technology Conference, scheduled for September 14-15, 2026. Brian Poff, EVP and CFO, and Brad Bickham, COO on an Interim Basis, will represent the company. A live broadcast and replay of their presentation will be available on Addus HomeCare's website starting September 15, 2026.
(ADUS) as a Liquidity Pulse for Institutional Tactics
This article analyzes Addus Homecare Corporation (NASDAQ: ADUS) using AI models to provide institutional trading strategies. It identifies weak near-term sentiment but compelling upside potential due to the absence of resistance levels above the current price. The analysis includes position trading, momentum breakout, and risk hedging strategies, along with multi-timeframe signal analysis for various holding periods.
Are Options Traders Betting on a Big Move in Addus HomeCare Stock?
Options traders are showing significant interest in Addus HomeCare Corporation (ADUS), indicated by the high implied volatility of its Oct. 16, 2026 $95 Put option. While this suggests expectations for a substantial price movement, analysts currently rate ADUS as a Zacks Rank #3 (Hold), with recent earnings estimate revisions showing a slight decrease. This divergence between high implied volatility and a neutral fundamental outlook could signal a potential trading opportunity for seasoned options traders looking to sell premium.
Are Options Traders Betting on a Big Move in Addus HomeCare Stock?
Options traders are showing significant interest in Addus HomeCare Corporation (ADUS) with high implied volatility for the Oct. 16, 2026 $95 Put, suggesting an expectation of a large price movement. Despite this, analysts currently rate ADUS as a Zacks Rank #3 (Hold), with recent earnings estimate adjustments. The article suggests this high implied volatility could indicate a potential trading opportunity for those looking to sell premium.
The Bull Case For Addus HomeCare (ADUS) Could Change Following COO Leadership Shift - Learn Why
Addus HomeCare (ADUS) announced a leadership change with Heather Dixon's departure as President and COO, and the return of former COO Brad Bickham as interim COO for one year. Bickham's prior experience with Addus's core services and acquisition program is expected to provide stability during this transition. Investors will focus on how effectively Addus deploys its balance sheet for accretive deals, especially with Bickham's past involvement in building the company's platforms.
Great Lakes Advisors LLC Invests $2.70 Million in Addus HomeCare Corporation $ADUS
Great Lakes Advisors LLC has invested $2.70 million in Addus HomeCare Corporation, acquiring 26,836 shares, representing about 0.14% of the company. Institutional investors collectively own 95.35% of ADUS. Addus HomeCare recently reported strong quarterly earnings, surpassing analyst estimates with $1.73 EPS and an 8% year-over-year revenue increase to $377.41 million.
18,120 Shares in Addus HomeCare Corporation $ADUS Bought by Aurora Investment Counsel
Aurora Investment Counsel recently acquired a new stake of 18,120 shares in Addus HomeCare Corporation (NASDAQ:ADUS), valued at approximately $1,821,000. Other institutional investors have also adjusted their holdings in the company, which now has 95.35% institutional ownership. Despite an insider stock sale, Addus HomeCare's stock saw a 1.6% increase, and analysts project an EPS of 6.29 for the current fiscal year, with a "Moderate Buy" rating.
Summit Creek Advisors LLC Acquires Shares of 85,118 Addus HomeCare Corporation $ADUS
Summit Creek Advisors LLC has acquired 85,118 shares of Addus HomeCare Corporation (ADUS), valued at approximately $8.55 million, making it their fifth-largest holding. Institutional investors own 95.35% of Addus HomeCare, with other major holders including BlackRock and Vanguard. The company recently reported strong quarterly earnings, exceeding analyst estimates, and maintains a "Moderate Buy" consensus rating from analysts with an average price target of $130.88.
TimesSquare Capital Management LLC Buys Shares of 313,549 Addus HomeCare Corporation $ADUS
TimesSquare Capital Management LLC has acquired 313,549 shares of Addus HomeCare Corporation (NASDAQ:ADUS) worth approximately $31.5 million, representing 1.68% of the company. Institutional investors now own 95.35% of ADUS, which holds a "Moderate Buy" rating from analysts with an average price target of $130.88. The company recently surpassed quarterly earnings expectations with $1.73 EPS and $377.41 million in revenue, an 8% increase year-over-year.
Rice Hall James & Associates LLC Takes $4.29 Million Position in Addus HomeCare Corporation $ADUS
Rice Hall James & Associates LLC has acquired a new stake of 42,704 shares, valued at approximately $4.29 million, in Addus HomeCare Corporation (NASDAQ:ADUS). Other institutional investors also increased their holdings, contributing to institutional ownership of 95.35% for the company. Analysts maintain a "Moderate Buy" rating with an average price target of $130.88, following the company's Q2 earnings which surpassed expectations with $1.73 EPS and $377.41 million in revenue.
Addus HomeCare (NASDAQ: ADUS) COO details equity stake
Addus HomeCare Corp's COO, W. Bradley Bickham, filed a Form 3 disclosing his initial equity stake in the company. He reported direct ownership of 34,678 shares of Common Stock as of August 7, 2026. The filing is an initial statement of beneficial ownership, not indicating a recent purchase or sale, and also references a Power of Attorney for filing-related actions.
Bank of America Corp DE Grows Stock Holdings in Addus HomeCare Corporation $ADUS
Bank of America Corp DE increased its stake in Addus HomeCare Corporation (NASDAQ:ADUS) by 11.3% in the first quarter, now owning 323,037 shares valued at approximately $30.3 million. Addus HomeCare recently reported strong quarterly earnings, beating analyst estimates with $1.73 EPS and an 8.0% year-over-year revenue increase. The company maintains a "Moderate Buy" consensus rating from analysts, with an average price target of $130.88.
Is Addus HomeCare’s Leadership Shake-Up And Earnings Beat Reframing the Investment Case For Addus (ADUS)?
Addus HomeCare (ADUS) recently announced a leadership change, with President and COO Heather Dixon departing and former President and COO Brad Bickham returning as interim COO, alongside reporting stronger Q2 2026 earnings. This shake-up, coupled with improved profitability and a focus on larger acquisitions, is influencing the company's investment narrative. While the company aims for significant revenue and earnings growth by 2029, investors should consider potential risks like rising labor costs and heavy reliance on Medicaid.
Why Did Addus HomeCare (ADUS) Move Today?
Addus HomeCare (ADUS) saw its stock price climb following the departure of its President and COO, Heather Dixon, and the return of Brad Bickham as interim COO. Despite this leadership change and recent Q2 results, analysts believe ADUS is undervalued, citing expected state-level reimbursement rate increases. However, potential Medicare reimbursement cuts and workforce shortages pose risks to future growth and margins.
Brad Bickham Returns as Addus HomeCare Interim COO
Addus HomeCare Corporation announced that Heather Dixon, president and chief operating officer, has left the company. Brad Bickham, former president and chief operating officer, will return as interim COO for one year, effective immediately. CEO Dirk Allison expressed gratitude for Dixon's contributions and confidence in Bickham's ability to ensure a seamless transition due to his extensive experience with the company.
Addus HomeCare Appoints W. Bradley Bickham as Interim COO Following Heather Dixon's Exit
Addus HomeCare Corporation announced the departure of President and COO Heather Dixon, effective August 7, 2026. W. Bradley Bickham has been appointed as interim Chief Operating Officer, also effective August 7, 2026. Bickham, who previously served as President and COO, will have an annual base salary of $622,000 and his employment agreement extends through July 31, 2027.
Addus HomeCare (ADUS) COO Heather Dixon exits as veteran leader Brad Bickham returns
Addus HomeCare Corporation announced that President and COO Heather Dixon left the company on August 7, 2026. Veteran leader W. Bradley Bickham, who previously served as President and COO, has been appointed as interim Chief Operating Officer. Bickham's employment agreement will run through July 31, 2027, with an annualized base salary of $622,000.
Wasatch Advisors LP Has $68.41 Million Stake in Addus HomeCare Corporation $ADUS
Wasatch Advisors LP has reduced its stake in Addus HomeCare Corporation (NASDAQ:ADUS) by 21.5% during the second quarter, selling 186,899 shares, but still holds 680,926 shares valued at $68.41 million. Addus HomeCare reported strong quarterly earnings, beating analyst estimates with $1.73 EPS and an 8% revenue increase year-over-year. Analysts maintain a "Moderate Buy" rating with an average price target of $130.88, while institutional investors own 95.35% of the stock.
Addus HomeCare COO departs, former executive returns interim By Investing.com
Addus HomeCare Corporation (NASDAQ:ADUS) announced the departure of its President and Chief Operating Officer, Heather Dixon. Brad Bickham, a former President and COO, will return on an interim basis for one year. CEO Dirk Allison thanked Dixon for her contributions, while highlighting Bickham's past role in expanding the company's services and acquisition strategy.
Addus appoints Bickham to role of interim COO following departure of Dixon
Addus HomeCare announced that President and COO Heather Dixon has departed the company, with former President and COO Brad Bickham returning as interim COO for a year. The announcement follows Addus's strong second-quarter earnings, where profits rose by 24.9% and revenues grew by 8%. CEO Dirk Allison praised Bickham's deep operational knowledge and thanked Dixon for her contributions.
Addus HomeCare Announces Departure of Heather Dixon and Return of Brad Bickham as Chief Operating Officer on an Interim Basis
Addus HomeCare Corporation announced the departure of Heather Dixon, President and Chief Operating Officer. Brad Bickham, former President and COO, will return as Chief Operating Officer on an interim basis for one year, effective immediately. The company expressed gratitude to Heather Dixon for her contributions and welcomed Brad Bickham back for his deep operational knowledge and leadership during this transition period.
Addus COO Departs; CenterWell Names New President Of Home Solutions
Heather Dixon, COO of Addus HomeCare, has left the company, with Brad Bickham stepping in as interim COO. Concurrently, CenterWell appointed Casey McKeon as president of home solutions to lead Humana’s home care strategy. The article also details several other significant leadership changes and appointments across various home care and health service companies, including HarmonyCares, National Alliance for Care at Home, Always Best Care, and Maxim Healthcare.
Addus HomeCare COO departs, former executive returns interim
Addus HomeCare Corporation announced the departure of Heather Dixon, President and Chief Operating Officer. Brad Bickham, a former President and COO, will return on an interim basis for one year. CEO Dirk Allison expressed gratitude for Dixon's contributions, while highlighting Bickham's previous role in the company's expansion and acquisition strategy in hospice and home health services.
Addus HomeCare Names Brad Bickham Interim COO Following Heather Dixon’s Departure
Addus HomeCare Corporation (Nasdaq: ADUS) has appointed Brad Bickham as interim Chief Operating Officer following the departure of Heather Dixon. Bickham, previously the company's President and COO, will serve for one year to ensure operational continuity during the leadership transition. CEO Dirk Allison thanked Dixon for her contributions and expressed confidence in Bickham's ability to oversee the company's extensive home care operations and growth strategy.
Addus HomeCare Corporation (NASDAQ:ADUS) Second-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year
Addus HomeCare Corporation recently released its Q2 results, prompting analysts to update their financial forecasts for the current fiscal year. The company's stock has seen a significant increase in price target from analysts, reflecting optimism about its future performance. Key changes in analyst expectations and the impact of these revisions on the company's valuation are detailed.
Addus HomeCare Corporation $ADUS Position Decreased by Empowered Funds LLC
Empowered Funds LLC significantly reduced its stake in Addus HomeCare Corporation (ADUS) by 62.3% in Q1 2026, selling over 44,000 shares. Despite this, institutional investors still own a substantial 95.35% of the company, and analysts maintain a "Moderate Buy" consensus with an average price target of $130.88. Addus HomeCare reported strong Q1 earnings, surpassing EPS estimates and showing an 8% year-over-year revenue increase.
Addus on the Hunt for M&A Deals
Addus Homecare is actively seeking mergers and acquisitions in home care and skilled home health to expand its market reach and increase geographic density. The company, which closed one personal care acquisition and has another in the works, reported strong financial performance in the first half of 2026, with significant increases in net service revenues and adjusted EBITDA. Addus also indicated it is open to home health transactions and is focused on maintaining a balanced patient mix in its hospice segment despite some payment cap liability.
Addus HomeCare Q2 Momentum Seen Continuing, RBC Says
RBC Capital Markets believes Addus HomeCare (ADUS) will continue its strong Q2 momentum into the second half of 2026, driven by improved staffing, acquisition benefits, and higher reimbursement rates. The firm expects ADUS to achieve double-digit organic growth and views it as a top pick among its home health coverage, reiterating an Outperform rating.
RBC Capital Adjusts Price Target on Addus HomeCare to $134 From $130, Maintains Outperform Rating
RBC Capital has increased its price target for Addus HomeCare (NASDAQ:ADUS) to $134 from $130, while reiterating an Outperform rating on the stock. This adjustment suggests a positive outlook on the company's financial performance or market position. Investors should note this change in analyst sentiment.
Addus revenues jump 8%, as personal care and hospice expansion offset home health decline
Addus HomeCare reported an 8% year-over-year revenue increase in Q2 2026, reaching $377.4 million, driven by strong performance in its personal care and hospice divisions. CEO Dirk Allison announced plans for continued growth through mergers and acquisitions, particularly in personal care and home health care, fueled by cash reserves and optimism from a proposed CMS rate increase for 2027. Despite a decline in home health revenue, the company anticipates a strong finish to 2026 with a projected 12% to 13% increase.
Addus HomeCare Corp 2Q 2026: Revenue $377.42M, EPS $1.49— 10-Q Summary
Addus HomeCare Corp reported its second-quarter 2026 results, showing significant growth in revenue and diluted EPS. The company's revenue increased by 8% to $377.42 million, and diluted EPS rose by 24.2% to $1.49, primarily driven by organic personal care growth and strategic acquisitions. Addus HomeCare expanded its personal care footprint through five acquisitions, while also noting an increased managed care mix and mixed clinical trends with strong hospice growth but declining home health volumes.
Addus HomeCare Eyes More M&A As HomeCourt Deal Exceeds Expectations
Addus HomeCare Corporation's recent acquisition of HomeCourt Home Care has surpassed expectations, primarily due to higher client volume. This success, along with strong Q2 financial performance, is fueling Addus's strategy for further acquisitions and expansion into new markets. The company is also implementing a technology transition to a single EMR platform to enhance its "bridge program," which connects personal care with home health and hospice services.
Earnings call transcript: Addus HomeCare beats Q2 2026 estimates, shares fall 5.4%
Addus HomeCare reported higher-than-expected Q2 2026 earnings and revenue, with adjusted EPS of $1.73 and revenue of $377.4 million, beating analyst estimates. Despite the beat, the company's shares fell by 5.4% due to the narrow margin of the beat and mixed segment trends. Management expressed optimism for the second half of 2026, anticipating improved personal care census growth and home health performance, and is actively pursuing M&A opportunities while maintaining a strong balance sheet.
Addus HomeCare (ADUS) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
Addus HomeCare (ADUS) reported strong Q2 2026 earnings, with revenue up 8% year-over-year to $377.42 million, beating the Zacks Consensus Estimate. EPS also surpassed expectations at $1.73. The company saw significant growth in personal care revenue, though home health and hospice segments experienced smaller changes compared to estimates.
Addus HomeCare Q2 revenue rises 8% to $377.4 million
Addus HomeCare reported an 8% increase in Q2 2026 net service revenues, reaching $377.4 million, with net income rising to $27.6 million. The company's adjusted EBITDA grew by 11.9% year-over-year, and it held $99.6 million in cash as of June 30, 2026. Insider trading shows significant sales activity, while institutional investors had mixed movements in their holdings.
